Page last updated: 2024-08-17

isobutyric acid and Action Myoclonus-Renal Failure Syndrome

isobutyric acid has been researched along with Action Myoclonus-Renal Failure Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, M; Wu, X; Xu, R; Xu, T; Ying, M; Zhu, H; Zhuang, Y	1

Other Studies

1 other study(ies) available for isobutyric acid and Action Myoclonus-Renal Failure Syndrome

Article	Year
Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA. The Journal of biological chemistry, 2006, May-05, Volume: 281, Issue:18 Topics: Acetylation; Animals; Brain; Butyrates; Disease Models, Animal; Histones; Humans; Isobutyrates; Mice; Mice, Transgenic; Myoclonic Epilepsies, Progressive; Nerve Tissue Proteins; Neurodegenerative Diseases; Peptides; Phenotype	2006

Article

Year

Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA.

The Journal of biological chemistry, 2006, May-05, Volume: 281, Issue:18

Topics: Acetylation; Animals; Brain; Butyrates; Disease Models, Animal; Histones; Humans; Isobutyrates; Mice; Mice, Transgenic; Myoclonic Epilepsies, Progressive; Nerve Tissue Proteins; Neurodegenerative Diseases; Peptides; Phenotype

2006